
Gregory Williams turned to regenerative medicine for healing after a one-two punch to his health. The 63-year-old Florida man survived leukemia only to develop ocular graft-versus-host disease, a potentially blinding complication of the bone marrow transplant that put his cancer in remission.
Ocular graft-versus-host disease is a chronic debilitating condition with no cure that causes severe dry eyes. The Regenerative Medicine Therapeutic Suites in Florida, recognizing an unmet patient need, began producing and offering a treatment known as autologous serum eyedrops to regenerate moisture. These eyedrops are made from a patient's own blood.
The Mayo Clinic Center for Regenerative Medicine has been a driver of advancing regenerative care, together with the Regenerative Medicine Therapeutic Suites, as a leader in outpatient regenerative procedures.
"Autologous serum eyedrops are considered a compound medication that is manufactured from serum extracted from a patient's own blood. The eyedrops utilize cells and growth factors to modify the ocular surface and restore the body's ability to produce natural tears," says Jennifer Arthurs, a nurse practitioner in the Regenerative Medicine Therapeutic Suites.
Read the rest of the article on the Center for Regenerative Medicine blog.
____________________________________________
Other Mayo Clinic medical research websites:
Cancer remains the second-leading cause of death in the U.S., but the number of people dying from cancer continues to decline. In the last three ...
February is National Cancer Prevention Month, and Saturday, Feb. 4, is World Cancer Day, which is a global initiative to raise awareness, improve education and promote ...
Black History Month is commemorated every February. It's a month for all people to celebrate and learn about diverse and important contributions of African Americans ...